Error message

The page you requested does not exist. For your convenience, a search was performed using the query trials ncrn 2352 pisarro.

Search results

  1. Dr Alasdair Russell

    ... we use these novel models in a range of pre-clinical trials to advance our understanding of disease. ...

  2. Dr Amos Burke

    ... role he is responsible for the delivery of clinical cancer trials for Children and Young People in England. ...

  3. Mr Angelos Kolias

    ... but the main emphasis is on the conduct of randomised trials. For his methodological work, he is collaborating with the IDEAL group ... is the Co-Chief Investigator of four NIHR-funded randomised trials and the Associate Director of the NIHR Global Health Research Group on ...

  4. Dr Basma Greef

    ... develop new treatments. My other interests include clinical trials and the effective management of toxicities related to widely used ...

  5. Dr Brent O'Carrigan

    - Phase 2/3 clinical trials in renal cancer and melanoma ...

  6. Dr Bristi Basu

    ... findings on lead candidate agents into early phase clinical trials of novel therapeutic drugs as chief investigator, principal investigator ... and industry-sponsored Phase I, II and III clinical trials, including first-in-human and first-in-class studies. My tumour ...

  7. Professor Charlotte Coles

    ... of recurrence. She is Chief Investigator of 4 clinical trials with linked translational research: 1. IMPORT LOW : phase III ...

  8. Ms Ceilidh Welsh

    ... from nearly 3000 patients recruited across radiotherapy trials in Breast Cancer, Prostate Cancer and Head & Neck Cancer. ...

  9. Dr Danish Mazhar

    ... He is the Principal Investigator of numerous clinical trials in Prostate, Bladder and Testis Cancers. He is a member of National ...

  10. Dr David Gilligan

    ... tract cancer and is an enthusiastic participator in clinical trials. He has been a member of the NCRI Lung Cancer Studies Group. He is ...

  11. Dr Helen Hatcher

    ... and psychological impacts of cancer. She is a member of the NCRN sarcoma clinical studies group and lead investigator in several ...

  12. Dr Hanna Najgebauer

    Open Targets Postdoctoral Fellow responsible for the development of new algorithms and computational tools for scoring cancer in vitro models based on their clinical relevance and covered genomic heterogeneity observed in primary disease.

Pages